Is Melanoma Progression Affected by Thyroid Diseases?

BRAF mutations cancer estrogen melanoma papillary thyroid cancer thyroid diseases thyroid hormone

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Sep 2022
Historique:
received: 29 07 2022
revised: 25 08 2022
accepted: 31 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data suggest that, in addition to thyroid hormones, other hormonal players of the hypothalamic-pituitary-thyroid (HPT) axis, namely the thyrotropin releasing hormone and the thyrotropin, are likely to affect melanoma cells behavior. This information warrants further clinical and experimental studies in order to build a precise pattern of action of the HPT hormones on melanoma cells. An improved knowledge of the involved molecular mechanism(s) could lead to a better and possibly personalized clinical management of these patients.

Identifiants

pubmed: 36077430
pii: ijms231710036
doi: 10.3390/ijms231710036
pmc: PMC9456309
pii:
doi:

Substances chimiques

Thyroid Hormones 0
Thyrotropin 9002-71-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Clin Med. 2021 Sep 30;10(19):
pubmed: 34640574
J Clin Med. 2021 Oct 15;10(20):
pubmed: 34682867
Thyroid. 2019 Jul;29(7):946-955
pubmed: 30957677
Endocr Dev. 2013;24:1-10
pubmed: 23392090
PLoS Genet. 2016 Aug 05;12(8):e1006239
pubmed: 27494611
Eur J Cancer. 2020 Feb;126:141-158
pubmed: 31928887
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Radiat Res. 2010 Dec;174(6):741-52
pubmed: 21128798
Cancers (Basel). 2021 Mar 19;13(6):
pubmed: 33808717
Eur J Cancer. 2019 Mar;109:21-27
pubmed: 30682533
Int J Mol Sci. 2019 May 24;20(10):
pubmed: 31137683
Horm Cancer. 2020 Apr;11(2):111-116
pubmed: 32172474
Lancet Oncol. 2021 May;22(5):643-654
pubmed: 33857412
J Clin Aesthet Dermatol. 2019 Sep;12(9):39-41
pubmed: 31641417
Int J Endocrinol. 2018 Jul 5;2018:1742951
pubmed: 30123257
Clin Endocrinol (Oxf). 2012 Nov;77(5):780-6
pubmed: 22702340
Contemp Oncol (Pozn). 2014;18(5):302-6
pubmed: 25477750
Biochim Biophys Acta. 1990 Dec 11;1032(2-3):157-76
pubmed: 2261492
Cancers (Basel). 2020 Jun 01;12(6):
pubmed: 32492864
PLoS One. 2015 Mar 31;10(3):e0122958
pubmed: 25826596
Breast Cancer Res Treat. 2014 Apr;144(3):683-8
pubmed: 24604093
Oncol Ther. 2020 Jun;8(1):103-114
pubmed: 32700073
J Med Case Rep. 2022 Jan 18;16(1):29
pubmed: 35039080
J Invest Dermatol. 2022 Aug;142(8):2217-2227
pubmed: 34990694
Am J Physiol Cell Physiol. 2009 May;296(5):C980-91
pubmed: 19158403
J Natl Cancer Inst. 2015 Aug 20;107(11):
pubmed: 26296643
Cancer Epidemiol. 2020 Feb;64:101664
pubmed: 31884334
Cancer Epidemiol. 2020 Jun;66:101707
pubmed: 32222650
Front Oncol. 2021 Jul 02;11:675296
pubmed: 34277420
Thyroid. 2009 Apr;19(4):355-60
pubmed: 19355826
Ann Dermatol. 2010 Aug;22(3):370-2
pubmed: 20711283
Mol Endocrinol. 1997 Aug;11(9):1278-90
pubmed: 9259319
J Cell Physiol. 2013 May;228(5):968-74
pubmed: 23042505
Trends Pharmacol Sci. 2017 Jan;38(1):92-99
pubmed: 27979317
J Endocrinol. 2010 Feb;204(2):105-14
pubmed: 19767412
J Clin Oncol. 2013 Jun 20;31(18):2337-46
pubmed: 23690423
Cancer Chemother Pharmacol. 2016 Jul;78(1):167-71
pubmed: 27286994
J Clin Endocrinol Metab. 2011 Feb;96(2):504-8
pubmed: 21106716
Peptides. 1999;20(3):395-400
pubmed: 10447100
Nature. 1986 Dec 18-31;324(6098):641-6
pubmed: 2879243
Horm Cancer. 2018 Jun;9(3):139-143
pubmed: 29441459
Lancet Oncol. 2015 May;16(5):522-30
pubmed: 25840693
Nat Rev Endocrinol. 2016 Feb;12(2):111-21
pubmed: 26668118
Lancet. 2018 Sep 15;392(10151):971-984
pubmed: 30238891
Nat Commun. 2022 Jul 9;13(1):4000
pubmed: 35810190
PLoS One. 2015 Mar 25;10(3):e0121514
pubmed: 25807528
Br J Dermatol. 2021 Aug;185(2):282-293
pubmed: 34060071
N Engl J Med. 2017 Nov 9;377(19):1824-1835
pubmed: 28891423
Endocr Relat Cancer. 2016 Dec;23(12):R577-R595
pubmed: 27807061
Diagnostics (Basel). 2021 Jul 30;11(8):
pubmed: 34441308
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Anticancer Res. 2015 Apr;35(4):2431-4
pubmed: 25862910
Clin Cancer Res. 2012 Jan 15;18(2):400-7
pubmed: 22252256
Cancers (Basel). 2022 Feb 28;14(5):
pubmed: 35267557
Cancer Genet. 2016 Mar;209(3):75-81
pubmed: 26774355
Curr Opin Oncol. 2020 Mar;32(2):106-113
pubmed: 31876547
Breast Cancer. 2020 Sep;27(5):828-836
pubmed: 32279180
J Invest Dermatol. 2011 Mar;131(3):719-26
pubmed: 21150923
Eur J Cancer. 2020 Feb;126:159-177
pubmed: 31866016
J Invest Dermatol. 2002 Dec;119(6):1449-55
pubmed: 12485453
Curr Genomics. 2011 Dec;12(8):609-17
pubmed: 22654560
Nature. 1986 Dec 18-31;324(6098):635-40
pubmed: 2879242
Thyroid. 2006 Nov;16(11):1151-5
pubmed: 17123342
JAMA Otolaryngol Head Neck Surg. 2014 May;140(5):423-7
pubmed: 24626334
Int J Surg. 2017 May;41 Suppl 1:S7-S12
pubmed: 28506417
N Engl J Med. 2017 Nov 9;377(19):1813-1823
pubmed: 28891408
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Oncol Rep. 2018 May;39(5):2306-2314
pubmed: 29517106
Gland Surg. 2021 Jan;10(1):336-346
pubmed: 33633990
N Engl J Med. 2016 Nov 10;375(19):1845-1855
pubmed: 27717298
BMC Med. 2015 Sep 04;13:211
pubmed: 26337719
Endocrinology. 2003 Aug;144(8):3469-76
pubmed: 12865327
PLoS One. 2016 Nov 10;11(11):e0166152
pubmed: 27832141
Int J Mol Sci. 2019 Mar 20;20(6):
pubmed: 30897754
BioDrugs. 2013 Dec;27(6):615-28
pubmed: 23818056
Curr Oncol Rep. 2018 Sep 24;20(11):87
pubmed: 30250984
N Engl J Med. 2018 May 10;378(19):1789-1801
pubmed: 29658430
Oncol Rep. 2003 Sep-Oct;10(5):1317-20
pubmed: 12883700
Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):581-93
pubmed: 26303085
Nat Rev Endocrinol. 2014 Oct;10(10):582-91
pubmed: 25135573
Melanoma Res. 2001 Dec;11(6):633-7
pubmed: 11725210
Melanoma Res. 2011 Jun;21(3):244-52
pubmed: 21540649
J Invest Dermatol. 2010 Jan;130(1):93-101
pubmed: 19641516
Endocr Relat Cancer. 2014 Oct;21(5):797-811
pubmed: 25074669
Nat Genet. 2014 May;46(5):478-481
pubmed: 24686849
Clin Cancer Res. 2004 Aug 15;10(16):5531-6
pubmed: 15328193
Dermatol Online J. 2006 Feb 28;12(2):1
pubmed: 16638394
J Cutan Pathol. 2012 Sep;39(9):826-34
pubmed: 22804631
Front Oncol. 2022 May 06;12:901004
pubmed: 35600349
Cancers (Basel). 2020 Dec 04;12(12):
pubmed: 33291668
Br Med Bull. 2011;99:39-51
pubmed: 21893493
Br J Cancer. 2010 Apr 27;102(9):1397-9
pubmed: 20354521
Arch Pathol Lab Med. 2020 Apr;144(4):500-522
pubmed: 32057276
Endocr Rev. 2010 Apr;31(2):139-70
pubmed: 20051527
J Invest Dermatol. 2011 Dec;131(12):2368-77
pubmed: 21956127
Science. 2014 Sep 12;345(6202):1358-61
pubmed: 25170046
Clin Endocrinol (Oxf). 2008 Aug;69(2):342-4
pubmed: 18088396
JAMA Dermatol. 2019 May 1;155(5):604-609
pubmed: 30586141
Nat Rev Clin Oncol. 2020 Aug;17(8):450
pubmed: 32472086
Cells. 2021 Feb 10;10(2):
pubmed: 33578751
Rev Endocr Metab Disord. 2018 Dec;19(4):325-333
pubmed: 30242549
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Eur Thyroid J. 2012 Oct;1(3):208
pubmed: 24783022
Int J Mol Sci. 2022 May 20;23(10):
pubmed: 35628540
Gland Surg. 2018 Aug;7(Suppl 1):S19-S29
pubmed: 30175060
Int J Mol Sci. 2022 Mar 28;23(7):
pubmed: 35409084
J Clin Invest. 1990 Dec;86(6):1777-82
pubmed: 2254444
Eur J Endocrinol. 2016 Apr;174(4):R117-26
pubmed: 26510840
Br J Cancer. 2013 Oct 29;109(9):2496-501
pubmed: 24084773
Med Oncol. 2017 Feb;34(2):26
pubmed: 28074351
Gland Surg. 2020 Oct;9(5):1628-1638
pubmed: 33224840
Oncol Rep. 2018 May;39(5):2225-2234
pubmed: 29517103
J Invest Dermatol. 2009 May;129(5):1126-39
pubmed: 19052559
Front Oncol. 2020 Feb 11;10:91
pubmed: 32117745
Cancers (Basel). 2021 Nov 07;13(21):
pubmed: 34771729
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Br J Dermatol. 2019 Jul;181(1):105-113
pubmed: 30451293
Clin Exp Dermatol. 2020 Jun;45(4):512-514
pubmed: 31875997
Front Endocrinol (Lausanne). 2020 Aug 25;11:551
pubmed: 32982963
EMBO J. 1999 Feb 1;18(3):623-31
pubmed: 9927422
Nucl Med Commun. 2016 Feb;37(2):110-5
pubmed: 26513055
Breast Cancer Res Treat. 2012 Jun;133(3):1169-77
pubmed: 22434524
J Clin Oncol. 2009 Dec 20;27(36):6199-206
pubmed: 19917835
Crit Rev Oncol Hematol. 2021 Aug;164:103425
pubmed: 34245855
J Clin Med. 2021 Sep 09;10(18):
pubmed: 34575184
Int J Endocrinol. 2017;2017:9692304
pubmed: 28348589
Mol Cell Endocrinol. 1994 Oct;105(1):45-53
pubmed: 7821717
Thyroid. 2011 Apr;21(4):367-71
pubmed: 21190444
Cells. 2020 Jul 20;9(7):
pubmed: 32698392
J Clin Endocrinol Metab. 1984 Sep;59(3):432-5
pubmed: 6086698
Langenbecks Arch Surg. 2011 Dec;396(8):1127-36
pubmed: 21487943
Endocr Relat Cancer. 2006 Dec;13(4):1269-77
pubmed: 17158770
Endocrinology. 2004 Jul;145(7):3265-72
pubmed: 15059947
Compr Physiol. 2016 Jun 13;6(3):1221-37
pubmed: 27347891
Curr Opin Cell Biol. 2014 Aug;29:1-7
pubmed: 24662021
Thyroid. 2013 Jul;23(7):879-84
pubmed: 23421548
Thyroid. 2021 Jul;31(7):1114-1126
pubmed: 33509032
J Otolaryngol Head Neck Surg. 2018 Jan 22;47(1):6
pubmed: 29357932
J Transl Med. 2022 Apr 5;20(1):156
pubmed: 35382855

Auteurs

Salvatore Ulisse (S)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Enke Baldini (E)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Daniele Pironi (D)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Federica Gagliardi (F)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Domenico Tripodi (D)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Augusto Lauro (A)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Sabino Carbotta (S)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Danilo Tarroni (D)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Matteo D'Armiento (M)

Scientific Direction, IRCCS San Gallicano Dermatological Institute, 00144 Rome, Italy.

Aldo Morrone (A)

Scientific Direction, IRCCS San Gallicano Dermatological Institute, 00144 Rome, Italy.

Flavio Forte (F)

Urology Department, M.G. Vannini Hospital, 00177 Rome, Italy.

Flaminia Frattaroli (F)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Severino Persechino (S)

Department of Neurosciences, Mental Health and Sensory Organs, "Sapienza" University of Rome, 00161 Rome, Italy.

Teresa Odorisio (T)

Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, 00167 Rome, Italy.

Vito D'Andrea (V)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Eleonora Lori (E)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Salvatore Sorrenti (S)

Department of Surgical Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH